Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$33.41 -0.11 (-0.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Lakefront Biotherapeutics (LKFT) Return on Equity [ROE] (2016 - 2026)

Updated

Lakefront Biotherapeutics' Return on Equity [ROE] came in at 9866.49% for the quarter ended Mar 31, 2026, up 9872.48 percentage points from -5.99% a year earlier but down 1406.31 percentage points from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Lakefront Biotherapeutics' Return on Equity [ROE] was 10676.41%, up 10673.80 percentage points from the prior year.

  • Return on Equity [ROE] carries a five-year change of +10687.61 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, Return on Equity [ROE] was 2.61% in the year ended Dec 31, 2024 (-5.42 pp), 8.03% in the year ended Dec 31, 2023 (+15.97 pp), -7.94% in the year ended Dec 31, 2022 (-3.98 pp) and -3.96% in the year ended Dec 31, 2021 (+7.24 pp).
  • The five-year range for quarterly Return on Equity [ROE] is -16.75% (the quarter ended Sep 30, 2025) to 11272.80% (the quarter ended Dec 31, 2025).
  • Year-over-year, Return on Equity [ROE] increased in two of the last four quarters, with an average year-over-year change of +5280.43 percentage points.
  • Business Quant data shows LKFT's Return on Equity [ROE] at 11272.80% (quarter ended Dec 31, 2025), -16.75% (quarter ended Sep 30, 2025) and -9.46% (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Lakefront Biotherapeutics 2.20 Bn 2.20 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 15.18%
Dec 31, 2025 11.78%
Sep 30, 2025 -16.42%
Jun 30, 2025 -9.17%
Mar 31, 2025 -5.99%
Dec 31, 2024 2.57%
Mar 31, 2024 9.69%
Dec 31, 2023 7.78%
Mar 31, 2023 -6.74%
Mar 31, 2022 -7.22%
Jun 30, 2020 -0.49%
Mar 31, 2020 1.84%
Dec 31, 2019 1.97%
Sep 30, 2019 10.00%
Jun 30, 2019 -5.66%
Mar 31, 2019 -4.84%
Dec 31, 2018 -4.03%
Sep 30, 2018 -4.15%
Jun 30, 2018 -15.79%
Mar 31, 2018 -14.07%
API Access

Lakefront Biotherapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LKFT&period=max&api_key=YOUR_API_KEY